Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
Genital warts and other HPV infections: established and novel therapies
Ramin Fathi1, Maria M Tsoukas1
1Section on Dermatology, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637.
Abstract:
Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are currently lacking. Many factors are used in the selection of treatment. Variables that should be taken into account include but are not limited to the morphology of the lesions such as thickness and size, quantity, anatomic location, human papilloma virus (HPV) classification, immunocompromized or immune competent status, as well as the preferences of the patient and the provider, cost and availability. No current treatment completely eradicates the human papillomavirus virus. The availability of vaccinations against HPV infection is contributing to the decreasing incidence of this disease. This contribution highlights conventional therapies, off-label treatment strategies including combination therapies, and prophylaxis for condylomata acuminata.
Insights
Wart treatments aim to destroy lesions or modify immunity, but no single method is superior. Treatment choice depends on lesion characteristics, patient factors, and human papillomavirus (HPV) type.
Area of Science:
- Dermatology
- Immunology
- Virology
Background:
- Warts are caused by the human papillomavirus (HPV).
- Current therapies focus on lesion destruction or immune modulation.
- No single wart treatment demonstrates superiority for clearance or recurrence rates.
Purpose of the Study:
- To review conventional and off-label therapies for condylomata acuminata.
- To discuss factors influencing treatment selection for HPV-related lesions.
- To highlight the role of HPV vaccination in disease prevention.
Main Methods:
- Literature review of existing wart treatment strategies.
- Analysis of factors influencing clinical decision-making.
- Discussion of combination therapies and prophylaxis.
Main Results:
- Multiple therapeutic options exist, but comparative trials are limited.
- Treatment selection is multifactorial, involving lesion characteristics, patient status, and provider/patient preference.
- No treatment eradicates the HPV virus completely.
Conclusions:
- Optimal wart management requires individualized treatment plans.
- HPV vaccination is crucial for reducing disease incidence.
- Further research is needed for comparative treatment efficacy studies.
Related Concept Videos
Sexually Transmitted Infections
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Tumor Immunotherapy
Treatment Resistant Cancers

